{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:08:59Z","timestamp":1778724539624,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22377011"],"award-info":[{"award-number":["22377011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109881","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:39:14Z","timestamp":1776353954000},"page":"109881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A targeted drug conjugate derived from GNS561 and a Pt(II) moiety for PPT1-mediated lysosomal autophagy inhibition in triple-negative breast Cancer"],"prefix":"10.1016","volume":"176","author":[{"given":"Libo","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohua","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109881_bb0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3322\/caac.21777","article-title":"Systemic therapy for hormone receptor-positive\/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer","volume":"73","author":"Huppert","year":"2023","journal-title":"CA-Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.109881_bb0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/diagnostics13020272","article-title":"Theranostics for triple-negative breast cancer","volume":"13","author":"Choi","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.bioorg.2026.109881_bb0015","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/cac2.12352","article-title":"MiR-99a-5p modulates doxorubicin resistance via the COX-2\/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studies","volume":"42","author":"Garrido-Cano","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bioorg.2026.109881_bb0020","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1186\/s12885-019-5985-6","article-title":"A prospective investigation of oral contraceptive use and breast cancer mortality: findings from the swedish womens lifestyle and health cohort","volume":"19","author":"Nur","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioorg.2026.109881_bb0025","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2147\/BCTT.S426121","article-title":"Research progress on molecular subtyping and modern treatment of triple-negative breast cancer","volume":"15","author":"Tong","year":"2023","journal-title":"Breast Cancer-Targets Ther."},{"key":"10.1016\/j.bioorg.2026.109881_bb0030","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11010-023-04772-6","article-title":"Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC)","volume":"479","author":"Mustafa","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0035","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3390\/cancers14051253","article-title":"Triple negative breast cancer: updates on classification and treatment in 2021","volume":"14","author":"Bou Zerdan","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.109881_bb0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"Npj Breast Cancer"},{"key":"10.1016\/j.bioorg.2026.109881_bb0045","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3390\/cancers12040916","article-title":"The landscape of targeted therapies in TNBC","volume":"12","author":"Vagia","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.109881_bb0050","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1021\/acs.jmedchem.4c02403","article-title":"Discovery of a novel 1,4-benzodiazepine derivative as a highly selective ANXA3 degrader for the treatment of triple-negative breast cancer","volume":"68","author":"Liu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0055","doi-asserted-by":"crossref","first-page":"33889","DOI":"10.1074\/jbc.273.51.33889","article-title":"A new protein conjugation system in human","volume":"273","author":"Mizushima","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc3262","article-title":"Deconvoluting the context-dependent role for autophagy in cancer","volume":"12","author":"White","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.109881_bb0065","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41419-018-0866-5","article-title":"Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells","volume":"9","author":"Cristofani","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.109881_bb0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semcancer.2019.05.016","article-title":"Monitoring autophagy in cancer: from bench to bedside","volume":"66","author":"Long","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2026.109881_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108485","article-title":"Autophagy inhibitors for cancer therapy: small molecules and nanomedicines","volume":"249","author":"Chen","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2026.109881_bb0080","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1158\/2159-8290.CD-17-0741","article-title":"A unified approach to targeting the lysosome's degradative and growth signaling roles","volume":"7","author":"Rebecca","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2026.109881_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14612","article-title":"Misrouting of v-ATPase subunit v0a1 dysregulates lysosomal acidification in a neurodegenerative lysosomal storage disease model","volume":"8","author":"Bagh","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.109881_bb0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1158\/2159-8290.CD-18-0706","article-title":"PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer","volume":"9","author":"Rebecca","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2026.109881_bb0095","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4161\/auto.29119","article-title":"Combined MTOR and autophagy inhibition: phase i trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma","volume":"10","author":"Rangwala","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.bioorg.2026.109881_bb0100","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1080\/15548627.2021.1988357","article-title":"GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions","volume":"18","author":"Brun","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.bioorg.2026.109881_bb0105","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2026.109881_bb0110","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1021\/acs.jmedchem.1c00079","article-title":"Novel CK2-specific Pt(II) compound reverses cisplatin-induced resistance by inhibiting cancer cell stemness and suppressing DNA damage repair in non-small cell lung cancer treatments","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.phrs.2016.01.001","article-title":"Cisplatin resistance and opportunities for precision medicine","volume":"106","author":"Amable","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2026.109881_bb0120","doi-asserted-by":"crossref","first-page":"17163","DOI":"10.1074\/jbc.M114.558288","article-title":"Role of autophagy in cisplatin resistance in ovarian cancer cells","volume":"289","author":"Wang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0125","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.yexcr.2006.01.034","article-title":"Palmitoyl protein thioesterase 1 (PPT1) deficiency causes endocytic defects connected to abnormal saposin processing","volume":"312","author":"Ahtiainen","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bioorg.2026.109881_bb0130","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1021\/acs.jmedchem.4c03006","article-title":"Concept of targeted drug conjugate and its application in reversing drug resistance","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0135","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jcrc.2020.02.012","article-title":"Improving medication safety in the intensive care by identifying relevant drug-drug interactions - results of a multicenter delphi study","volume":"57","author":"Bakker","year":"2020","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.bioorg.2026.109881_bb0140","doi-asserted-by":"crossref","first-page":"9661","DOI":"10.1021\/acs.jmedchem.5c00352","article-title":"Fluoxetine-conjugated platinum(IV) prodrugs targeting eEF2K and conquering multidrug resistance against triple-negative breast cancer","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0145","doi-asserted-by":"crossref","first-page":"16296","DOI":"10.1021\/acs.jmedchem.4c01175","article-title":"Developing a palladium(II) agent to overcome multidrug resistance and metastasis of liver tumor by targeted multiacting on tumor cell, inactivating cancer-associated fibroblast and activating immune response","volume":"67","author":"Jiang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0150","doi-asserted-by":"crossref","first-page":"8020","DOI":"10.1021\/acs.jmedchem.4c00144","article-title":"Glycyrrhetinic acid as a hepatocyte targeting ligand-functionalized platinum(IV) complexes for hepatocellular carcinoma therapy and overcoming multidrug resistance","volume":"67","author":"Huang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155872","article-title":"Baicalin induces cell death of non-small cell lung cancer cells via MCOLN3-mediated lysosomal dysfunction and autophagy blockage","volume":"133","author":"Dong","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2026.109881_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104234","article-title":"Combination of DN604 with gemcitabine led to cell apoptosis and cell motility inhibition via p38 MAPK signaling pathway in NSCLC","volume":"104","author":"Wang","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0165","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/15548627.2023.2274253","article-title":"Ups and downs of lysosomal pH: conflicting roles of LAMP proteins?","volume":"20","author":"Handy","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.bioorg.2026.109881_bb0170","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1021\/acs.jmedchem.2c00472","article-title":"Platinum(IV) prodrugs with cancer stem cell inhibitory effects on lung cancer for overcoming drug resistance","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0175","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1021\/acs.jmedchem.2c02036","article-title":"Novel indole\u2013chalcone derivative-ligated platinum(IV) prodrugs attenuate cisplatin resistance in lung cancer through ROS\/ER stress and mitochondrial dysfunction","volume":"66","author":"Liu","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0180","doi-asserted-by":"crossref","first-page":"13587","DOI":"10.1021\/acs.jmedchem.3c00922","article-title":"Ligustrazine-derived chalcones-modified platinum(IV) complexes intervene in cisplatin resistance in pancreatic cancer through ferroptosis and apoptosis","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0185","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1021\/acs.jmedchem.4c02682","article-title":"Discovery of novel SHP2 ATTEC degraders against pancreatic ductal adenocarcinoma harboring KRAS(G12D) mutations","volume":"68","author":"Zhong","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0190","article-title":"Real-time monitoring of lysosomal membrane permeabilization using acridine orange","volume":"6","author":"Eriksson","year":"2023","journal-title":"Methods Protoc."},{"key":"10.1016\/j.bioorg.2026.109881_bb0195","doi-asserted-by":"crossref","first-page":"16899","DOI":"10.1021\/acs.jmedchem.4c01874","article-title":"A lysosome-targeting hNEU1 inhibitor treats myocardial infarction: a potential therapeutic breakthrough","volume":"67","author":"Zhou","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109881_bb0200","doi-asserted-by":"crossref","first-page":"8858","DOI":"10.1021\/acs.jmedchem.3c00455","article-title":"Discovery and structural optimization of novel quinolone derivatives as potent irreversible pan-fibroblast growth factor receptor inhibitors for treating solid tumors","volume":"66","author":"Hu","year":"2023","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:27:26Z","timestamp":1778722046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826004177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":40,"alternative-id":["S0045206826004177"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109881","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A targeted drug conjugate derived from GNS561 and a Pt(II) moiety for PPT1-mediated lysosomal autophagy inhibition in triple-negative breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109881"}}